These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1977679)

  • 1. Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ.
    Bartkova J; Barnes DM; Millis RR; Gullick WJ
    Hum Pathol; 1990 Nov; 21(11):1164-7. PubMed ID: 1977679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?
    Barnes DM; Bartkova J; Camplejohn RS; Gullick WJ; Smith PJ; Millis RR
    Eur J Cancer; 1992; 28(2-3):644-8. PubMed ID: 1350456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of neu protein overexpression in clinging in situ duct carcinoma of the breast.
    De Potter CR; Foschini MP; Schelfhout AM; Schroeter CA; Eusebi V
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(5):375-80. PubMed ID: 8100656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-erbB-2 oncogene protein in in situ and invasive lobular breast neoplasia.
    Porter PL; Garcia R; Moe R; Corwin DJ; Gown AM
    Cancer; 1991 Jul; 68(2):331-4. PubMed ID: 1676930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics.
    Tsang WY; Chan JK
    Am J Surg Pathol; 1996 Aug; 20(8):921-43. PubMed ID: 8712293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen and progesterone receptor and c-erbB-2 oncoprotein analysis in pure in situ breast carcinoma: an immunohistochemical study.
    Wilbur DC; Barrows GH
    Mod Pathol; 1993 Mar; 6(2):114-20. PubMed ID: 8097877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast.
    Lodato RF; Maguire HC; Greene MI; Weiner DB; LiVolsi VA
    Mod Pathol; 1990 Jul; 3(4):449-54. PubMed ID: 2170971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between c-erbB-2 immunoreactivity and thymidine labelling index in breast carcinoma in situ.
    Barnes DM; Meyer JS; Gonzalez JG; Gullick WJ; Millis RR
    Breast Cancer Res Treat; 1991 Mar; 18(1):11-7. PubMed ID: 1677296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of c-erbB-2 in in situ and in adjacent invasive ductal adenocarcinomas of the female breast.
    Maguire HC; Hellman ME; Greene MI; Yeh I
    Pathobiology; 1992; 60(3):117-21. PubMed ID: 1352687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
    Poller DN; Silverstein MJ; Galea M; Locker AP; Elston CW; Blamey RW; Ellis IO
    Mod Pathol; 1994 Feb; 7(2):257-62. PubMed ID: 7911998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical c-erbB-2 protooncogene expression and nuclear DNA content in human mammary carcinoma in situ.
    Schimmelpenning H; Eriksson ET; Pallis L; Skoog L; Cedermark B; Auer GU
    Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S48-52. PubMed ID: 1374218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical detection of oestrogen receptors in ductal carcinoma in situ of the breast.
    Karayiannakis AJ; Bastounis EA; Chatzigianni EB; Makri GG; Alexiou D; Karamanakos P
    Eur J Surg Oncol; 1996 Dec; 22(6):578-82. PubMed ID: 9005143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical distribution of c-erbB-2 in infiltrating and in situ breast cancer.
    Gusterson BA; Machin LG; Gullick WJ; Gibbs NM; Powles TJ; Price P; McKinna A; Harrison S
    Int J Cancer; 1988 Dec; 42(6):842-5. PubMed ID: 2903851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.
    van de Vijver MJ; Peterse JL; Mooi WJ; Wisman P; Lomans J; Dalesio O; Nusse R
    N Engl J Med; 1988 Nov; 319(19):1239-45. PubMed ID: 2903446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 protein expression in mammary ductal carcinoma in situ: relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein.
    Poller DN; Roberts EC; Bell JA; Elston CW; Blamey RW; Ellis IO
    Hum Pathol; 1993 May; 24(5):463-8. PubMed ID: 8098318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p53 protein in infiltrating and in-situ breast carcinomas.
    Walker RA; Dearing SJ; Lane DP; Varley JM
    J Pathol; 1991 Nov; 165(3):203-11. PubMed ID: 1684809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical localisation of pS2 protein in ductal carcinoma in situ and benign lesions of the breast.
    Luqmani YA; Campbell T; Soomro S; Shousha S; Rio MC; Coombes RC
    Br J Cancer; 1993 Apr; 67(4):749-53. PubMed ID: 8385977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of scatter factor and c-met receptor in benign and malignant breast tissue.
    Jin L; Fuchs A; Schnitt SJ; Yao Y; Joseph A; Lamszus K; Park M; Goldberg ID; Rosen EM
    Cancer; 1997 Feb; 79(4):749-60. PubMed ID: 9024713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-erbB-2 protein and neuroendocrine expression in intraductal carcinomas of the breast.
    Lilleng R; Hagmar BM; Nesland JM
    Mod Pathol; 1992 Jan; 5(1):41-7. PubMed ID: 1347423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear and flow cytometric characteristics associated with overexpression of the c-erbB-2 oncoprotein in breast carcinoma.
    Poller DN; Galea M; Pearson D; Bell J; Gullick WJ; Elston CW; Blamey RW; Ellis IO
    Breast Cancer Res Treat; 1991 Dec; 20(1):3-10. PubMed ID: 1687505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.